Navigation Links
Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment
Date:12/17/2009

SAN DIEGO, Dec. 17 /PRNewswire/ -- Suneva Medical, a privately-held aesthetic medical device company, today announced that it has signed a multi-million dollar line of credit facility with Western Technology Investment (WTI). The line of credit facility will be used to fund commercial support for Artefill®, the only FDA-approved microsphere-enhanced collagen dermal filler on the market today, as well as to expand Suneva's Aesthetic Market growth objectives.

"Today Suneva Medical entered into a multi-million dollar line of credit deal with WTI with the objective of funding the growth initiatives for both Artefill and Suneva," said Niv Caviar, President and Chief Executive Officer of Suneva Medical. "This additional capital from WTI combined with the financial commitment and support we continue to receive from Cowen Healthcare Royalty Partners, well-positions Suneva as we look ahead to 2010 and our near term goal of profitability. We are pleased to be working with WTI, a premier debt capital provider and a firm that has a successful reputation of supporting growth enterprises to reach their financial goals."

The WTI investment was led by Jay Cohan and David Wanek. "We are happy to be entering into this strategic capital alliance with Suneva," said Jay Cohan, Investment Partner at WTI. "We feel confident that our capital commitment coupled with Cowen's existing and future capital commitment will help accelerate the company's growth trajectory."

Mr. Caviar continued, "With Artefill's outstanding sales growth in the few months since the product's re-launch, we are confident in the traction that we've gained among our targeted group of physicians in the dermatology, plastic and cosmetic surgery markets. With our additional funding, we will continue to promote Artefill to physicians who wish to offer their patients a safe and long-term option versus the temporary fillers currently in the market."

About Artefill

Artefill is the first and only FDA-approved microsphere-enhanced collagen filler for the correction of nasolabial folds, better known as smile lines. Since Artefill was approved in 2006, over 20,000 patients have been treated successfully with very high satisfaction rates. For more information visit www.artefill.com.

About Suneva Medical

Suneva Medical, Inc. is a medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets. The Company's lead product is Artefill®, the first and only microsphere-enhanced collagen filler for the correction of nasolabial folds, or smile lines. For more information visit www.sunevamedical.com.

About Western Technology Investment

Founded in 1980, Western Technology Investment (WTI) is the world's leading venture debt fund, financing venture-backed companies in the technology, healthcare and cleantech industries. WTI's 12th fund builds upon the firm's successful history, which has included investments in Ablation Frontiers, Brocade, Cerent, Evalve, Facebook, Google, IDEC Pharmaceuticals, Infoseek, IronPort, Juniper Networks, NanoSolar, Postini, Transmeta, and many others. For more information, please visit www.westerntech.com.


    Media and PR Contact:                       Investor Contact:
    Larry Milocco, Sr. Dir Marketing            Phil Ranker, VP, CFO
    Suneva Medical                              Suneva Medical
    (858) 550-9999 x7844                        (858) 550-9999 x5648

SOURCE Suneva Medical


'/>"/>
SOURCE Suneva Medical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer
2. First Patient Treated in Clinical Study of Cohera Medicals TissuGlu(R) Surgical Adhesive
3. Greenway Medical Technologies PrimeSuite Wins Three Best in KLAS Awards
4. Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer
5. Flextronics Completes SloMedical Acquisition
6. Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping Unreasonable, Unfair and Discriminatory
7. Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]
8. Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call
9. Under Johnnies(TM) Proven To Increase Patient Satisfaction by OBP Medical Inc.
10. Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability
11. Greenway Medical Technologies PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... , Sept. 6, 2017  Medical ... knowledge and skills while treating their patients. ... hands-on experience without involving patients. Simulation provides ... Clinicians can carry out procedures, refine techniques ... risk. Integration of new technology, such as ...
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... Sept. 5, 2017  Getinge, a leading global ... vibrant charitable donation program -- "Color for the ... heart defect research by The Children,s Heart Foundation. ... general public are encouraged to download a coloring ... completed artwork to the gallery on the website. ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... ... “They Sang At Her Funeral”: a tale of murder that will bring ... their closets. “They Sang At Her Funeral” is the creation of published author, Annalise ... five children and twelve grandchildren. Before becoming a writer, Annalise had the opportunity to ...
(Date:9/19/2017)... ... 2017 , ... Only a few physicians were selected to receive the prestigious ... Clevens, MD, FACS . The founder and medical director of Clevens Face and ... at Yale, Harvard and the University of Michigan. He has served patients throughout Central ...
(Date:9/19/2017)... ... , ... Trusted debt-reduction firm CreditAssociates, LLC has announced two important milestones. To ... $835 million in resolved debt for its clients. , Credit card debt, unpaid hospital ... of debt settled by the company. With more than a decade of combined service ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... Texas as a part of its national Swirl: A Wine Tasting Event series ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has ... filter. When we’re born, Nature gives us a full supply of melanin – ... we continuously lose this natural glare-reducing pigment; however, around the age of thirty, we ...
Breaking Medicine News(10 mins):